Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Labcorp Holdings Inc. (LH)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Labcorp Holdings Inc..
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 920148.
Total stock buying since 2015: $1,043,003.
Total stock sales since 2015: $222,322,901.
Total stock option exercises since 2015: $77,979,648.
Table 3. Detailed insider trading at Labcorp Holdings Inc. (LH) , Part 4
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2018-02-07 | Mittelstaedt Robert E Jr (Director) | Option Ex | 1,263 | .00 | 0 |
| 2018-02-07 | Belingard Jean-luc (Director) | Option Ex | 1,263 | .00 | 0 |
| 2018-02-07 | Berberian Lance (SVP, Chief Information Officer) | Option Ex | 296 | .00 | 0 |
| 2017-10-30 | Gilliland Dwight Gary (Director) | Sale | 971 | 153.52 | 149,067 |
| 2017-09-06 | King David P (President & CEO) | Sale | 44,687 | 157.05 | 7,018,227 |
| 2017-09-06 | King David P (President & CEO) | Option Ex | 44,687 | 90.74 | 4,054,898 |
| 2017-09-05 | King David P (President & CEO) | Sale | 132,713 | 157.06 | 20,843,372 |
| 2017-09-05 | King David P (President & CEO) | Option Ex | 132,713 | 90.74 | 12,042,377 |
| 2017-09-01 | Gary M. Huff (CEO, LabCorp Diagnostics) | Option Ex | 153 | .00 | 0 |
| 2017-08-25 | Eberts F Samuel Iii (Chief Legal Officer, Secretary) | Sale | 31,500 | 155.22 | 4,889,461 |
| 2017-08-25 | Eberts F Samuel Iii (Chief Legal Officer, Secretary) | Option Ex | 31,500 | 68.61 | 2,161,120 |
| 2017-08-11 | Williams R Sanders (Director) | Sale | 3,100 | 156.85 | 486,241 |
| 2017-08-11 | Williams R Sanders (Director) | Option Ex | 3,100 | 77.19 | 239,289 |
| 2017-08-01 | Uthgenannt Lisa J (Chief Human Resources Officer) | Sale | 5,000 | 160.00 | 800,000 |
| 2017-08-01 | Dodson Edward T (Principal Accounting Officer) | Sale | 2,871 | 160.13 | 459,730 |
| 2017-08-01 | Eisenberg Glenn A (Chief Financial Officer, EVP) | Sale | 5,968 | 159.46 | 951,669 |
| 2017-06-16 | Eisenberg Glenn A (Chief Financial Officer, EVP) | Option Ex | 4,050 | .00 | 0 |
| 2017-05-22 | Berberian Lance (SVP, Chief Information Officer) | Sale | 3,613 | 139.84 | 505,259 |
| 2017-05-09 | Belingard Jean-luc (Director) | Sale | 992 | 142.19 | 141,052 |
| 2017-05-09 | Belingard Jean-luc (Director) | Option Ex | 992 | 77.58 | 76,959 |
| 2017-03-11 | Uthgenannt Lisa J (Chief Human Resources Officer) | Option Ex | 8,217 | .00 | 0 |
| 2017-03-11 | Dodson Edward T (Principal Accounting Officer) | Option Ex | 400 | .00 | 0 |
| 2017-03-11 | King David P (President & CEO) | Option Ex | 6,077 | .00 | 0 |
| 2017-03-11 | Eberts F Samuel Iii (Chief Legal Officer, Secretary) | Option Ex | 463 | .00 | 0 |
| 2017-03-11 | Eisenberg Glenn A (Chief Financial Officer, EVP) | Option Ex | 1,627 | .00 | 0 |
| 2017-03-11 | Berberian Lance (SVP, Chief Information Officer) | Option Ex | 400 | .00 | 0 |
| 2017-03-09 | Eisenberg Glenn A (Chief Financial Officer, EVP) | Sale | 2,300 | 142.47 | 327,671 |
| 2017-02-24 | Anderson Kerrii B (Director) | Option Ex | 1,000 | 75.63 | 75,630 |
| 2017-02-24 | Mittelstaedt Robert E Jr (Director) | Sale | 5,300 | 142.69 | 756,283 |
| 2017-02-24 | Mittelstaedt Robert E Jr (Director) | Option Ex | 5,300 | 75.63 | 400,839 |
| 2017-02-23 | Anderson Kerrii B (Director) | Sale | 1,992 | 140.00 | 278,880 |
| 2017-02-23 | Anderson Kerrii B (Director) | Option Ex | 1,992 | 76.61 | 152,597 |
| 2017-02-11 | Dodson Edward T (Principal Accounting Officer) | Option Ex | 550 | .00 | 0 |
| 2017-02-11 | Eberts F Samuel Iii (Chief Legal Officer, Secretary) | Option Ex | 634 | .00 | 0 |
| 2017-02-09 | Uthgenannt Lisa J (Chief Human Resources Officer) | Option Ex | 603 | .00 | 0 |
| 2017-02-09 | Dodson Edward T (Principal Accounting Officer) | Option Ex | 450 | .00 | 0 |
| 2017-02-09 | Gilliland Dwight Gary (Director) | Option Ex | 1,560 | .00 | 0 |
| 2017-02-09 | Ratliff John D (CEO, Covance Drug Development) | Option Ex | 6,100 | .00 | 0 |
| 2017-02-09 | Parham Richelle P (Director) | Option Ex | 1,560 | .00 | 0 |
| 2017-02-09 | Kong Garheng (Director) | Option Ex | 1,560 | .00 | 0 |
| 2017-02-09 | Schechter Adam H (Director) | Option Ex | 1,560 | .00 | 0 |
| 2017-02-09 | Williams R Sanders (Director) | Option Ex | 1,560 | .00 | 0 |
| 2017-02-09 | King David P (President & CEO) | Option Ex | 7,543 | .00 | 0 |
| 2017-02-09 | Neupert Peter M (Director) | Option Ex | 1,560 | .00 | 0 |
| 2017-02-09 | Eberts F Samuel Iii (Chief Legal Officer, Secretary) | Option Ex | 520 | .00 | 0 |
| 2017-02-09 | Anderson Kerrii B (Director) | Option Ex | 1,560 | .00 | 0 |
| 2017-02-09 | Eisenberg Glenn A (Chief Financial Officer, EVP) | Option Ex | 4,876 | .00 | 0 |
| 2017-02-09 | Mittelstaedt Robert E Jr (Director) | Option Ex | 1,560 | .00 | 0 |
| 2017-02-09 | Belingard Jean-luc (Director) | Option Ex | 1,560 | .00 | 0 |
| 2017-02-09 | Berberian Lance (SVP, Chief Information Officer) | Option Ex | 3,496 | .00 | 0 |
| 2016-08-09 | Uthgenannt Lisa J (Chief Human Resources Officer) | Sale | 1,177 | 140.00 | 164,780 |
| 2016-08-04 | Eisenberg Glenn A (Chief Financial Officer, EVP) | Sale | 8,000 | 140.38 | 1,123,000 |
| 2016-08-04 | Mittelstaedt Robert E Jr (Director) | Sale | 992 | 140.15 | 139,026 |
| 2016-08-04 | Mittelstaedt Robert E Jr (Director) | Option Ex | 992 | 77.58 | 76,959 |
| 2016-06-16 | Eisenberg Glenn A (Chief Financial Officer, EVP) | Option Ex | 8,100 | .00 | 0 |
| 2016-06-13 | King David P (President & CEO) | Sale | 196,400 | 128.42 | 25,221,491 |
| 2016-06-13 | King David P (President & CEO) | Option Ex | 196,400 | 70.15 | 13,777,460 |
| 2016-04-29 | Uthgenannt Lisa J (Chief Human Resources Officer) | Sale | 3,740 | 125.17 | 468,135 |
| 2016-04-27 | Dodson Edward T (Principal Accounting Officer) | Sale | 9,392 | 126.42 | 1,187,336 |
| 2016-03-31 | Boyle James T. Jr. (EVP,CEO of LabCorp Diagnostics) | Sale | 18,132 | 116.93 | 2,120,174 |
| 2016-03-31 | Eberts F Samuel Iii (Chief Legal Officer, Secretary) | Sale | 4,219 | 116.85 | 492,990 |
| 2016-03-14 | Boyle James T. Jr. (EVP,CEO of LabCorp Diagnostics) | Sale | 1,543 | 115.32 | 177,938 |
| 2016-03-14 | Eberts F Samuel Iii (Chief Legal Officer, Secretary) | Sale | 309 | 115.32 | 35,633 |
| 2016-03-11 | Uthgenannt Lisa J (Chief Human Resources Officer) | Option Ex | 8,216 | .00 | 0 |
| 2016-03-11 | Dodson Edward T (Principal Accounting Officer) | Option Ex | 400 | .00 | 0 |
| 2016-03-11 | Gilliland Dwight Gary (Director) | Option Ex | 1,237 | .00 | 0 |
| 2016-03-11 | Boyle James T. Jr. (EVP,CEO of LabCorp Diagnostics) | Option Ex | 2,956 | .00 | 0 |
| 2016-03-11 | Kong Garheng (Director) | Option Ex | 1,237 | .00 | 0 |
| 2016-03-11 | Schechter Adam H (Director) | Option Ex | 1,237 | .00 | 0 |
| 2016-03-11 | Williams R Sanders (Director) | Option Ex | 1,237 | .00 | 0 |
| 2016-03-11 | Keller Deborah L (CEO, Covance Drug Development) | Option Ex | 12,930 | .00 | 0 |
| 2016-03-11 | King David P (President & CEO) | Option Ex | 6,076 | .00 | 0 |
| 2016-03-11 | Neupert Peter M (Director) | Option Ex | 1,237 | .00 | 0 |
| 2016-03-11 | Eberts F Samuel Iii (Chief Legal Officer, Secretary) | Option Ex | 463 | .00 | 0 |
| 2016-03-11 | Anderson Kerrii B (Director) | Option Ex | 1,237 | .00 | 0 |
| 2016-03-11 | Eisenberg Glenn A (Chief Financial Officer, EVP) | Option Ex | 1,626 | .00 | 0 |
| 2016-03-11 | Mittelstaedt Robert E Jr (Director) | Option Ex | 1,237 | .00 | 0 |
| 2016-03-11 | Belingard Jean-luc (Director) | Option Ex | 1,237 | .00 | 0 |
| 2016-03-11 | Berberian Lance (SVP, Chief Information Officer) | Option Ex | 400 | .00 | 0 |
| 2016-02-25 | Belingard Jean-luc (Director) | Sale | 1,296 | 109.72 | 142,203 |
| 2016-02-25 | Belingard Jean-luc (Director) | Option Ex | 1,296 | 59.37 | 76,943 |
| 2016-02-16 | Boyle James T. Jr. (EVP,CEO of LabCorp Diagnostics) | Sale | 4,055 | 103.02 | 417,746 |
| 2016-02-16 | Eberts F Samuel Iii (Chief Legal Officer, Secretary) | Sale | 370 | 103.02 | 38,117 |
| 2016-01-08 | Eberts F Samuel Iii (Chief Legal Officer, Secretary) | Sale | 1,215 | 119.05 | 144,645 |
| 2015-12-08 | Eberts F Samuel Iii (Chief Legal Officer, Secretary) | Sale | 1,010 | 123.31 | 124,543 |
| 2015-11-02 | Williams R Sanders (Director) | Sale | 1,850 | 124.30 | 229,958 |
| 2015-11-02 | Williams R Sanders (Director) | Option Ex | 1,850 | 64.42 | 119,177 |
| 2015-10-29 | Anderson Kerrii B (Director) | Option Ex | 1,296 | 59.37 | 76,943 |
| 2015-08-03 | King David P (President & CEO) | Sale | 50,000 | 128.06 | 6,402,900 |
| 2015-08-03 | King David P (President & CEO) | Option Ex | 50,000 | 80.37 | 4,018,500 |
| 2015-07-31 | Herring Joseph L (CEO of Covance Drug Division) | Option Ex | 19,990 | .00 | 0 |
| 2015-07-01 | King David P (President & CEO) | Sale | 50,000 | 121.72 | 6,086,200 |
| 2015-07-01 | King David P (President & CEO) | Option Ex | 50,000 | 80.37 | 4,018,500 |
| 2015-06-16 | Eisenberg Glenn A (Chief Financial Officer, EVP) | Option Ex | 4,050 | .00 | 0 |
| 2015-06-01 | King David P (President & CEO) | Sale | 50,000 | 118.23 | 5,911,500 |
| 2015-06-01 | King David P (President & CEO) | Option Ex | 50,000 | 80.37 | 4,018,500 |
| 2015-05-19 | Mittelstaedt Robert E Jr (Director) | Sale | 1,296 | 119.02 | 154,249 |
| 2015-05-19 | Mittelstaedt Robert E Jr (Director) | Option Ex | 1,296 | 59.37 | 76,943 |
| 2015-05-11 | Williams R Sanders (Director) | Sale | 965 | 118.06 | 113,929 |
| 2015-04-29 | Belingard Jean-luc (Director) | Sale | 1,542 | 123.10 | 189,820 |
| 2015-04-29 | Belingard Jean-luc (Director) | Option Ex | 1,542 | 49.93 | 76,992 |
| 2015-04-23 | Boyle James T. Jr. (EVP,CEO of LabCorp Diagnostics) | Sale | 1,394 | 126.56 | 176,424 |
| 2015-04-01 | Gilliland Dwight Gary (Director) | Option Ex | 172 | .00 | 0 |
| 2015-03-31 | Brecher Mark E (CMO, LabCorp Diagnostics) | Sale | 347 | 127.00 | 44,069 |
| 2015-03-30 | Brecher Mark E (CMO, LabCorp Diagnostics) | Sale | 20,278 | 126.98 | 2,574,940 |
| 2015-03-30 | Brecher Mark E (CMO, LabCorp Diagnostics) | Option Ex | 19,200 | 87.80 | 1,685,760 |
| 2015-03-03 | Boyle James T. Jr. (EVP, Chief Operating Officer) | Sale | 1,237 | 123.70 | 153,021 |
| 2015-02-26 | Williams R Sanders (Director) | Sale | 2,267 | 123.96 | 281,024 |
| 2015-02-25 | Herring Joseph L (CEO of Covance Drug Division) | Sale | 36,876 | 121.79 | 4,491,201 |
| 2015-02-13 | Boyle James T. Jr. (EVP, Chief Operating Officer) | Sale | 3,883 | 116.66 | 452,990 |
| 2015-02-12 | Dodson Edward T (Principal Accounting Officer) | Option Ex | 547 | .00 | 0 |
| 2015-02-12 | Brecher Mark E (Chief Medical Officer) | Option Ex | 547 | .00 | 0 |
| 2015-02-12 | Boyle James T. Jr. (EVP, Chief Operating Officer) | Sale | 2,714 | 116.71 | 316,750 |
| 2015-02-12 | Boyle James T. Jr. (EVP, Chief Operating Officer) | Option Ex | 6,170 | .00 | 0 |
| 2015-02-12 | King David P (President & CEO) | Option Ex | 8,270 | .00 | 0 |
| 2015-02-12 | Eberts F Samuel Iii (Chief Legal Officer, Secretary) | Option Ex | 547 | .00 | 0 |
| 2015-02-12 | Eisenberg Glenn A (Chief Financial Officer, EVP) | Option Ex | 1,540 | .00 | 0 |
| 2015-02-11 | Dodson Edward T (Principal Accounting Officer) | Option Ex | 550 | .00 | 0 |
| 2015-02-11 | Brecher Mark E (Chief Medical Officer) | Option Ex | 563 | .00 | 0 |
| 2015-02-11 | Boyle James T. Jr. (EVP, Chief Operating Officer) | Option Ex | 4,056 | .00 | 0 |
| 2015-02-11 | King David P (President & CEO) | Option Ex | 8,343 | .00 | 0 |
| 2015-02-11 | Eberts F Samuel Iii (Chief Legal Officer, Secretary) | Option Ex | 633 | .00 | 0 |
| 2015-02-11 | Eisenberg Glenn A (Chief Financial Officer, EVP) | Option Ex | 1,673 | .00 | 0 |
| 2015-02-10 | Gilliland Dwight Gary (Director) | Option Ex | 1,503 | .00 | 0 |
| 2015-02-10 | Kong Garheng (Director) | Option Ex | 1,503 | .00 | 0 |
| 2015-02-10 | Schechter Adam H (Director) | Option Ex | 1,503 | .00 | 0 |
| 2015-02-10 | Williams R Sanders (Director) | Option Ex | 1,503 | .00 | 0 |
| 2015-02-10 | Neupert Peter M (Director) | Option Ex | 1,503 | .00 | 0 |
| 2015-02-10 | Anderson Kerrii B (Director) | Option Ex | 1,503 | .00 | 0 |
| 2015-02-10 | Mittelstaedt Robert E Jr (Director) | Option Ex | 1,503 | .00 | 0 |
| 2015-02-10 | Belingard Jean-luc (Director) | Option Ex | 1,503 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
of LH listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Labcorp Holdings Inc. (symbol LH,
CIK number 920148) see
the Securities and Exchange Commission (SEC) website.